Document Detail

Tear tryptase in vernal keratoconjunctivitis.
MedLine Citation:
PMID:  11231766     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: To determine the tear level of tryptase (a marker of mast cell activation) in vernal keratoconjunctivitis (VKC) before and after treatment. In addition, eosinophil counts in conjunctival scrapings and ocular surface temperature before and after treatment were studied. PATIENTS AND METHODS: A total of 20 patients, 7 years or older with VKC, were included in this study. Tear samples for tryptase determination were collected before and 2 weeks after treatment with 4% disodium cromoglycate eyedrops and 0.1% fluorometholone eyedrops. In addition, conjunctival scrapings were obtained for microscopic evaluation, and measurement of the ocular surface temperature was performed before and 2 weeks after treatment. One patient was excluded because the patient did not receive topical treatment. Control tear samples were collected from 20 normal control patients for tryptase determination. RESULTS: There were 19 patients with VKC (17 males, 2 females). The age range was 7 to 17 years with a mean age of 9 years. The mean number of eosinophils prior to initiation of therapy was 11.37 eosinophils with a range of 1 to 34 per high-power field. Following treatment, the mean number of eosinophils was 3.42 eosinophils per high-power field with a range of 0 to 11 (P<.01). The mean ocular surface temperature for the right eye before treatment was 35.56 degrees C (range, 34.46 degrees C-36.50 degrees C) and after treatment was 33.53 degrees C (range, 31.13 degrees C-35.40 degrees C). For the left eye, the mean ocular surface temperature before treatment was 35.49 degrees C (range, 34.86 degrees C-36.16 degrees C) and after treatment was 33.88 degrees C (range, 32.40 degrees C-35.53 degrees C). The ocular surface temperature was found to decrease significantly following treatment (P<.001). The levels of tryptase in tears of patients with VKC were determined before and after treatment. The mean level was 16.77 ng/mL (range, <5-115 ng/mL). Following treatment with topical 4% disodium cromoglycate and 0.1% fluorometholone eyedrops, the mean level of tryptase decreased to 7.29 ng/mL (range, <5-44.1 ng/mL) (P<.05). CONCLUSIONS: Patients with severe VKC had high levels of tryptase in tears. Following treatment, the level of tryptase in tears decreased significantly.
K F Tabbara
Related Documents :
19395536 - Long-term results of low rotation humeral osteotomy in children with erb's obstetric br...
14563466 - Effects of mud pack treatment on skin microcirculation.
17130246 - Arthroscopic distal clavicle resection in athletes: a prospective comparison of the dir...
19664506 - Arthroscopic glenoid resurfacing as a surgical treatment for glenohumeral arthritis in ...
11566456 - Extended outpatient therapy with low molecular weight heparin for the treatment of recu...
9811186 - Severe aplastic anemia induced by ticlopidine: report of two cases.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Archives of ophthalmology     Volume:  119     ISSN:  0003-9950     ISO Abbreviation:  Arch. Ophthalmol.     Publication Date:  2001 Mar 
Date Detail:
Created Date:  2001-03-20     Completed Date:  2001-04-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7706534     Medline TA:  Arch Ophthalmol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  338-42     Citation Subset:  AIM; IM    
Department of Ophthalmology, College of Medicine, King Saud University, Riyadh 11534, Saudi Arabia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Allergens / adverse effects
Anti-Allergic Agents / therapeutic use
Conjunctivitis, Allergic / drug therapy,  enzymology*,  etiology
Cromolyn Sodium / therapeutic use
Drug Therapy, Combination
Fluorometholone / therapeutic use
Leukocyte Count
Ophthalmic Solutions
Serine Endopeptidases / metabolism*
Tears / enzymology*
Reg. No./Substance:
0/Allergens; 0/Anti-Allergic Agents; 0/Ophthalmic Solutions; 15826-37-6/Cromolyn Sodium; 426-13-1/Fluorometholone; EC 3.4.21.-/Serine Endopeptidases; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Increased corneal thickness in patients with ocular hypertension.
Next Document:  Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angl...